Locally Recurrent Lung Non-Small Cell Carcinoma
specificThe reemergence of lung non-small cell carcinoma after a period of remission, at or adjacent to the site of the original tumor.
10
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Locally Recurrent Lung Non-Small Cell Carcinoma(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive | 55.0 |
| 2 | NCI Comprehensive | 55.0 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 55.0 |
| 4 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 55.0 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 55.0 |
| 6 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 55.0 |
| 7 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 55.0 |
| 8 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 55.0 |
| 9 | 55.0 | |
| 10 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 55.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →